SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2'deoxycytidine to increase SPARC expression and improve therapy response (Q33331870)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2'deoxycytidine to increase SPARC expression and improve therapy response	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

25 July 2017

SPARC promoter hypermethylation in colorectal cancers can be reversed by 5-Aza-2'deoxycytidine to increase SPARC expression and improve therapy response (English)

1 reference

Europe PubMed Central

25 July 2017

hypermethylation

1 reference

based on heuristic

inferred from title

1 reference

ORCID Public Data File 2021

author name string

S Cheetham

1

1 reference

Europe PubMed Central

25 July 2017

M J Tang

2

1 reference

Europe PubMed Central

25 July 2017

F Mesak

3

1 reference

Europe PubMed Central

25 July 2017

H Kennecke

4

1 reference

Europe PubMed Central

25 July 2017

D Owen

5

1 reference

Europe PubMed Central

25 July 2017

I T Tai

6

1 reference

Europe PubMed Central

25 July 2017

language of work or name

0 references

publication date

6 May 2008

1 reference

Europe PubMed Central

25 July 2017

British Journal of Cancer

1 reference

Europe PubMed Central

25 July 2017

98

1 reference

Europe PubMed Central

25 July 2017

11

1 reference

Europe PubMed Central

25 July 2017

1810-1819

1 reference

Europe PubMed Central

25 July 2017

https://scigraph.springernature.com/pub.10.1038/sj.bjc.6604377

0 references

A novel interaction between procaspase 8 and SPARC enhances apoptosis and potentiates chemotherapy sensitivity in colorectal cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2410109

21 June 2018

Frequent inactivation of SPARC by promoter hypermethylation in colon cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2410109

21 June 2018

Discovery of novel methylation biomarkers in cervical carcinoma by global demethylation and microarray analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2410109

21 June 2018

Low or absent SPARC expression in acute myeloid leukemia with MLL rearrangements is associated with sensitivity to growth inhibition by exogenous SPARC protein

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2410109

21 June 2018

Absence of host-secreted protein acidic and rich in cysteine (SPARC) augments peritoneal ovarian carcinomatosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2410109

21 June 2018

Survey of differentially methylated promoters in prostate cancer cell lines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2410109

21 June 2018

SPARC expression is associated with impaired tumor growth, inhibited angiogenesis and changes in the extracellular matrix

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2410109

21 June 2018

Genome-wide expression analysis of therapy-resistant tumors reveals SPARC as a novel target for cancer therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2410109

21 June 2018

Array-based analysis of genomic DNA methylation patterns of the tumour suppressor gene p16INK4A promoter in colon carcinoma cell lines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2410109

21 June 2018

Aberrant methylation of SPARC in human lung cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2410109

21 June 2018

Enhanced growth of pancreatic tumors in SPARC-null mice is associated with decreased deposition of extracellular matrix and reduced tumor cell apoptosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2410109

21 June 2018

Enhanced growth of tumors in SPARC null mice is associated with changes in the ECM.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2410109

21 June 2018

Doxycycline-inducible expression of SPARC/Osteonectin/BM40 in MDA-MB-231 human breast cancer cells results in growth inhibition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2410109

21 June 2018

SPARC (secreted protein acidic and rich in cysteine) induces apoptosis in ovarian cancer cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2410109

21 June 2018

SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2410109

21 June 2018

SPARC, a matricellular protein: at the crossroads of cell-matrix communication

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2410109

21 June 2018

Inactivation of the apoptosis effector Apaf-1 in malignant melanoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2410109

21 June 2018

The genetic basis of colorectal cancer: insights into critical pathways of tumorigenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2410109

21 June 2018

CpG methylation is maintained in human cancer cells lacking DNMT1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2410109

21 June 2018

SPARC, a matricellular glycoprotein with important biological functions

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2410109

21 June 2018

CpG island methylator phenotype in colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2410109

21 June 2018

Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2410109

21 June 2018

Ki-ras mutations in adenomas: a characteristic of cancer-bearing colorectal mucosa.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2410109

21 June 2018

Lessons from hereditary colorectal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2410109

21 June 2018

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2410109

21 June 2018

Increased expression of osteonectin and osteopontin, two bone matrix proteins, in human breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2410109

21 June 2018

Treatment of acute leukemia with 5-azacytidine (NSC-102816).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2410109

21 June 2018

Osteonectin/SPARC/BM-40 in human decidua and carcinoma, tissues characterized by de novo formation of basement membrane

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2410109

21 June 2018

SPARC, a secreted protein associated with cellular proliferation, inhibits cell spreading in vitro and exhibits Ca+2-dependent binding to the extracellular matrix

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2410109

21 June 2018

Mutations in the p53 gene occur in diverse human tumour types

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2410109

21 June 2018

The expression of the secreted protein acidic and rich in cysteine (SPARC) is associated with the neoplastic progression of human melanoma.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6604377

21 January 2018

Aberrant CpG island hypermethylation of multiple genes in colorectal neoplasia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6604377

21 January 2018

Alteration of DNA methyltransferases contributes to 5'CpG methylation and poor prognosis in lung cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6604377

21 January 2018

Microsatellite instability: the mutator that mutates the other mutator

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6604377

21 January 2018

Bone-related genes expressed in advanced malignancies induce invasion and metastasis in a genetically defined human cancer model.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6604377

21 January 2018

5-Aza-2'-deoxycytidine (decitabine) can relieve p21WAF1 repression in human acute myeloid leukemia by a mechanism involving release of histone deacetylase 1 (HDAC1) without requiring p21WAF1 promoter demethylation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6604377

21 January 2018

Synergism between vitamin D and secreted protein acidic and rich in cysteine-induced apoptosis and growth inhibition results in increased susceptibility of therapy-resistant colorectal cancer cells to chemotherapy.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6604377

21 January 2018

Increased expression of unmethylated CDKN2D by 5-aza-2'-deoxycytidine in human lung cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6604377

21 January 2018

SPARC is a key Schwannian-derived inhibitor controlling neuroblastoma tumor angiogenesis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2410109

31 October 2018

Evaluation of candidate tumour suppressor genes on chromosome 18 in colorectal cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/18458674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Association between CpG island methylation and microsatellite instability in colorectal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18458674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

p15(INK4B) CpG island methylation in primary acute leukemia is heterogeneous and suggests density as a critical factor for transcriptional silencing

1 reference

https://pubmed.ncbi.nlm.nih.gov/18458674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Overexpression of SPARC protein contrasts with its transcriptional silencing by aberrant hypermethylation of SPARC CpG-rich region in endometrial carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/18458674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

SPARC/osteonectin is a frequent target for aberrant methylation in pancreatic adenocarcinoma and a mediator of tumor-stromal interactions

1 reference

https://pubmed.ncbi.nlm.nih.gov/18458674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of 5-azacytidine (NSC-102816) in the treatment of advanced gastrointestinal cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/18458674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

5-Azacytidine: a new active agent for the treatment of acute leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18458674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study on 5-aza-2′-deoxycytidine in children with acute leukemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/18458674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The EORTC Early Clinical Trials Cooperative Group experience with 5-aza-2'-deoxycytidine (NSC 127716) in patients with colo-rectal, head and neck, renal carcinomas and malignant melanomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/18458674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/18458674

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/SJ.BJC.6604377

1 reference

Europe PubMed Central

25 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

25 July 2017

1 reference

Europe PubMed Central

25 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33331870&oldid=1969622290"